Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VONVENDI® safely and effectively. See full prescribing information for VONVENDI. VONVENDI [von Willebrand factor (recombinant)] lyophilized powder for solution, for intravenous injection Initial U.S. Approval: 2015
Medication labelWhy this: Advisory · dailymed-other
VONVENDI® is indicated in adult and pediatric patients with von Willebrand disease (VWD) for: On-demand treatment and control of bleeding episodes. Perioperative management of bleeding. For adult patients only: Routine prophylaxis to reduce the frequency of bleeding episodes.,
- generic_name
- von willebrand factor (recombinant)
- brand_name
- water
- product_names
- von Willebrand Factor (Recombinant), water
- ndc
- 0944-7551, 0944-7553, 0944-7550, 0944-7552, 64764-515, 64764-516, 0944-7551-02, 0944-7550-01, 64764-515-50, 0944-7553-02, 0944-7552-01, 64764-516-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en